Concepedia

M Mannewitz

MM

3

Publications

204

Citations

3

H-Index

2017

Active since

Affiliations

Ludwig-Maximilians-Universität München(Current)

LMU Klinikum

Center for Integrated Protein Science Munich

University Hospital Augsburg

M Mannewitz is an author at Ludwig-Maximilians-Universität München specializing in cancer therapeutics, drug resistance, and tumor biology.

ORCID

Top concepts

Publications per year

2017–2022

3

Publications

3

Cisplatin resistance in non-small cell lung cancer cells is associated with an abrogation of cisplatin-induced G2/M cell cycle arrest

Navin Sarin, Florian Engel, Ganna V. Kalayda et al. · PLoS ONE · 2017 · 169 citations · Full text

, , +15

Presence of regulatory T-cells in endometrial cancer predicts poorer overall survival and promotes progression of tumor cells

Thomas Kolben, M Mannewitz, Carolin Perleberg et al. · Cellular Oncology · 2022 · 19 citations · Full text

Regulatory T Cell Apoptosis during Preeclampsia May Be Prevented by Gal-2

Sarah Meister, Laura Hahn, Susanne Beyer et al. · International Journal of Molecular Sciences · 2022 · 16 citations · Full text

Rows per page

1–3 of 3